User profiles for Novel N. Chegou

Novel N Chegou

Research Scientist (Professor) at Stellenbosch University
Verified email at sun.ac.za
Cited by 5410

Tuberculosis: advances and challenges in development of new diagnostics and biomarkers

…, M Bates, TD McHugh, NN Chegou… - The Lancet Infectious …, 2018 - thelancet.com
Tuberculosis remains the leading cause of death from an infectious disease worldwide. Early
and accurate diagnosis and detection of drug-sensitive and drug-resistant tuberculosis is …

Beyond the IFN-γ horizon: biomarkers for immunodiagnosis of infection with Mycobacterium tuberculosis

NN Chegou, J Heyckendorf, G Walzl… - European …, 2014 - Eur Respiratory Soc
Latent infection with Mycobacterium tuberculosis (LTBI) is defined by the presence of M.
tuberculosis-specific immunity in the absence of active tuberculosis. LTBI is detected using …

Tuberculosis assays: past, present and future

NN Chegou, KGP Hoek, M Kriel… - Expert review of anti …, 2011 - Taylor & Francis
Recent developments in the field of TB diagnostics, including the introduction of the Xpert
MTB/RIF assay in field testing, raise the hope for faster and more accurate identification of …

[HTML][HTML] Host markers in QuantiFERON supernatants differentiate active TB from latent TB infection: preliminary report

NN Chegou, GF Black, M Kidd, PD Van Helden… - BMC pulmonary …, 2009 - Springer
Background Interferon gamma release assays, including the QuantiFERON ® TB Gold In
Tube (QFT) have been shown to be accurate in diagnosing Mycobacterium tuberculosis …

[HTML][HTML] Host blood RNA signatures predict the outcome of tuberculosis treatment

…, DE Zak, N Du Plessis, AG Loxton, NN Chegou… - Tuberculosis, 2017 - Elsevier
Biomarkers for tuberculosis treatment outcome will assist in guiding individualized treatment
and evaluation of new therapies. To identify candidate biomarkers, RNA sequencing of …

Diagnostic performance of a seven-marker serum protein biosignature for the diagnosis of active TB disease in African primary healthcare clinic attendees with signs …

NN Chegou, JS Sutherland, S Malherbe, AC Crampin… - Thorax, 2016 - thorax.bmj.com
Background User-friendly, rapid, inexpensive yet accurate TB diagnostic tools are urgently
needed at points of care in resource-limited settings. We investigated host biomarkers …

Hypercytokinaemia accompanies HIV–tuberculosis immune reconstitution inflammatory syndrome

…, K Matthews, R Seldon, NN Chegou… - European …, 2011 - Eur Respiratory Soc
Increased access to combination antiretroviral therapy in areas co-endemic for tuberculosis (TB)
and HIV-1 infection is associated with an increased incidence of immune reconstitution …

[HTML][HTML] RISK6, a 6-gene transcriptomic signature of TB disease risk, diagnosis and treatment response

…, SC Mendelsohn, S Suliman, NN Chegou… - Scientific reports, 2020 - nature.com
Improved tuberculosis diagnostics and tools for monitoring treatment response are urgently
needed. We developed a robust and simple, PCR-based host-blood transcriptomic signature…

[HTML][HTML] Higher SARS-CoV-2 seroprevalence in workers with lower socioeconomic status in Cape Town, South Africa

…, T Cummins, NN Chegou, C Claassen, N Du Plessis… - Plos one, 2021 - journals.plos.org
Background Inequality is rife throughout South Africa. The first wave of COVID-19 may have
affected people in lower socioeconomic groups worse than the affluent. The SARS-CoV-2 …

Tuberculous meningitis: pathogenesis, immune responses, diagnostic challenges, and the potential of biomarker-based approaches

…, RS Solomons, G Walzl, NN Chegou - Journal of clinical …, 2021 - Am Soc Microbiol
Tuberculous meningitis (TBM) is the most devastating form of tuberculosis (TB), causing high
mortality or disability. Clinical management of the disease is challenging due to limitations …